- Home
- TAK vs CBRE Comparison
TAK vs CBRE Comparison
Compare TAK & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | CBRE |
|---|---|---|
| Founded | 1781 | 1906 |
| Country | Japan | United States |
| Employees | 47455 | 44000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.6B | 50.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | TAK | CBRE |
|---|---|---|
| Price | $16.35 | $146.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $177.86 |
| AVG Volume (30 Days) | ★ 3.0M | 1.7M |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.17% | N/A |
| EPS Growth | N/A | ★ 22.61 |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $40,550,000,000.00 |
| Revenue This Year | $0.16 | $14.31 |
| Revenue Next Year | $1.22 | $9.06 |
| P/E Ratio | ★ $41.25 | $137.62 |
| Revenue Growth | N/A | ★ 13.37 |
| 52 Week Low | $12.99 | $118.58 |
| 52 Week High | $18.90 | $174.27 |
Technical Indicators
Market Signals| Indicator | TAK | CBRE |
|---|---|---|
| Relative Strength Index (RSI) | 27.01 | 53.95 |
| Support Level | $15.63 | $127.40 |
| Resistance Level | $16.48 | $158.99 |
| Average True Range (ATR) | 0.22 | 4.48 |
| MACD | -0.19 | 0.48 |
| Stochastic Oscillator | 0.83 | 40.45 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.